中國綠寶(06183.HK):花旗銀行就500萬美元對公司提清盤呈請
格隆匯8月12日丨中國綠寶(06183.HK)公佈,公司接獲四名個人債券持有人,於2020年5月及6月針對公司於2019年發行的債券項下聲稱未償還的債務合共約3760萬港元提出的,對公司進行清盤的四份呈請。
公司亦接獲花旗銀行就500萬美元提出的,對公司進行清盤的呈請。
上述呈請安排於2020年8月、9月或10月於香港高等法院聆訊。公司正在就上述呈請諮詢法律意見,且正在積極處理相關呈請。公司未支付與呈請有關的若干聲稱未償還債務的主要原因為,公司注意到若干申索未必完全準確,及公司需要更多時間進行核實。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.